Concepedia

Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

T.M. Kim, Chan‐Young Ock, M. Kim, S.H. Kim, Bhumsuk Keam, Yoon Jun Kim, Dongwook Kim, J.-S. Lee, Dae Seog Heo

Annals of Oncology · 2019 · 34 citations · 0 references

DOIFull text

Open access

Concepts